Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05547529

The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

An Open-Label Randomized Clinical Trial to Evaluate the Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer cT3-4aN0M0, cT1-4aN1-3M0.

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
156 (estimated)
Sponsor
Blokhin's Russian Cancer Research Center · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the safety, feasibility and outcomes of neoadjuvant chemotherapy followed by esophagectomy versus neoadjuvant chemoradiotherapy followed by esophagectomy for locally advanced resectable esophageal squamous cell carcinoma cT3-4aN0M0, cT1-4aN1-3M0. This is non-inferiority study (neoadjuvant chemoradiotherapy has no advantage over neoadjuvant chemotherapy).

Detailed description

It is a prospective open-label randomized phase III clinical trial sponsored by N.N. Blokhin NMRC of Oncology. 156 patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0M0, cT1-4aN1-3M0) are recruited and randomly assigned into the neoadjuvant chemoradiotherapy group (nCRT) followed by esophagectomy and the neoadjuvant chemotherapy group (nCT) followed by esophagectomy according to the proportion of 1:1. The safety, efficacy of protocols and prognosis of patients are compared between the two regimens.

Conditions

Interventions

TypeNameDescription
PROCEDUREPatients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
PROCEDUREPatients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomyPatients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Timeline

Start date
2022-09-14
Primary completion
2025-09-14
Completion
2027-09-14
First posted
2022-09-21
Last updated
2022-10-04

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05547529. Inclusion in this directory is not an endorsement.